The Supreme Court will address a petition concerning a rare side-effect linked to the COVID-19 vaccine, known as Covishield, developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India. Chief Justice DY Chandrachud acknowledged the issue, which includes demands for an expert panel investigation and compensation for affected families.
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
